IFLAI

Exhibitor

IFLAI AB is a Swedish AI company developing efficient, high-performance models for scientific and industrial applications. Based at AstraZeneca R&D BioVentureHub in Mölndal, IFLAI operates at the intersection of advanced AI, life science, and real-world deployment.

Our approach is built on a clear principle: progress in AI should not depend only on larger models, more data, and greater computing power. Scientific and industrial organisations often operate with limited labelled data, costly experiments, sensitive information, instrument variability, and strict deployment requirements. IFLAI addresses these challenges by combining modern deep learning with physics-informed design, active learning, and efficient representation learning. The result is AI that delivers strong performance with substantially lower data, compute, energy, and infrastructure requirements.

In life science, IFLAI develops AI for drug discovery, phenotypic screening, microscopy, and cellular image analysis. Our CHROMA model family, including IFLAI CHROMA-1, transforms complex microscopy data into actionable biological representations, helping organisations train, validate, adapt, and deploy powerful screening models more efficiently.

Our technologies are built for the agentic AI era. IFLAI models and development tools are agent-ready, intelligent, and designed to operate within existing scientific and industrial workflows—not as isolated AI systems, but as active components capable of supporting decisions, coordinating tasks, and accelerating complex processes. This enables organisations to introduce advanced AI without rebuilding the workflows, infrastructure, and expertise they already rely on.

By making advanced AI more practical, scalable, and resource-efficient, IFLAI enables pharmaceutical, biotechnology, and industrial partners to move from complex data to better decisions—faster.

website